Why Recursion Pharmaceuticals (RXRX) Soared On Friday

Why Recursion Pharmaceuticals (RXRX) Soared On Friday
Recursion Pharmaceuticals' stock soared by 20.13% on Friday, closing at $5.49 per share after introducing Boltz-2, an advanced AI model for predicting binding affinity.